CYP2E1 genotype as a biomarker of cancer risk.

被引：0
|
作者：
Linder, MW
Valdes, RM
Hendler, FJ
Valdes, R
机构：
[1] UNIV LOUISVILLE,DEPT PATHOL,LOUISVILLE,KY 40292
[2] UNIV LOUISVILLE,DEPT BIOCHEM,LOUISVILLE,KY 40292
来源：
CLINICAL CHEMISTRY | 1996年 / 42卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：693 / 693
页数：1
相关论文
共 50 条
  • [1] Impact of CYP2E1 genotype in renal cell and urothelial cancer patients
    Farker, K
    Lehmann, MH
    Oelschlägel, B
    Haerting, J
    Hoffmann, A
    Janitzky, V
    Schubert, J
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1998, 50 (4-6) : 425 - 431
  • [2] CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 Allele Frequencies in Iranian Populations
    Shahriary, Ghazaleh Mohammadzadeh
    Galehdari, Hamid
    Jalali, Amir
    Zanganeh, Fatemeh
    Alavi, Seyed Mohammad Reza
    Aghanoori, Mohammad Reza
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) : 6505 - 6510
  • [3] Association of CYP2E1*6 polymorphism of gene CYP2E1 with the risk and severity of chronic hepatitis C
    Godovan, V. V.
    Ostapchuk, K. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2014, (03) : 67 - 70
  • [4] Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population
    Gulen Ulusoy
    Emel Arinç
    Orhan Adali
    Archives of Toxicology, 2007, 81 : 711 - 718
  • [5] CYP2E1 gene polymorphism and ovarian cancer risk in the Yakut population
    Khrunin, A. V.
    Ivanova, F. G.
    Moiseev, A. A.
    Gorbunova, V. A.
    Limborska, S. A.
    RUSSIAN JOURNAL OF GENETICS, 2011, 47 (12) : 1496 - 1498
  • [6] CYP2E1 gene polymorphism and ovarian cancer risk in the Yakut population
    A. V. Khrunin
    F. G. Ivanova
    A. A. Moiseev
    V. A. Gorbunova
    S. A. Limborska
    Russian Journal of Genetics, 2011, 47 : 1496 - 1498
  • [7] Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population
    Ulusoy, Gulen
    Arinc, Emel
    Adali, Orhan
    ARCHIVES OF TOXICOLOGY, 2007, 81 (10) : 711 - 718
  • [8] RsaI polymorphism at the CYP2E1 locus and risk of primary liver cancer
    Benitez, J
    Agundez, JAG
    Ladero, JM
    RodriguezLescure, A
    DiazRubio, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI21 - PI21
  • [9] GENETIC POLYMORPHISM IN CYP2E1: POPULATION DISTRIBUTION OF CYP2E1 ACTIVITY
    Neafsey, Pat
    Ginsberg, Gary
    Hattis, Dale
    Johns, Douglas O.
    Guyton, Kathryn Z.
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 362 - 388
  • [10] CYP2E1 and risk of chemically mediated cancers
    Trafalis, Dimitrios T.
    Panteli, Eleftheria S.
    Grivas, Anastasios
    Tsigris, Christos
    Karamanakos, Petros N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (03) : 307 - 319
12345